Mineralys Therapeutics, Inc.
MLYS
25 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | Jan 14 9:00 PM | Rodman David Malcom | Proposed Sale | 11,367 | $32.61 | $370.6K | — | View → |
| Jan 13, 2026 | Jan 13 9:10 PM | Rodman David Malcom | Proposed Sale | 7,709 | $32.75 | $252.5K | — | View → |
| Jan 12, 2026 | Jan 12 9:24 PM | Rodman David Malcom | Proposed Sale | 6,348 | $32.32 | $205.1K | — | View → |
| Jan 12, 2026 | Jan 12 9:23 PM | Levy Adam Scott | Proposed Sale | 10,758 | $32.14 | $345.7K | — | View → |
| Jan 12, 2026 | Jan 12 9:23 PM | Congleton Jon | Proposed Sale | 16,236 | $32.62 | $529.6K | — | View → |
| Jan 9, 2026 | Jan 9 9:23 PM | Rodman David Malcom | Proposed Sale | 2,170 | $33.27 | $72.2K | — | View → |
| Jan 2, 2026 | Jan 2 10:18 PM | Rodman David Malcom | Proposed Sale | 262,752 | $35.71 | $9.4M | — | View → |
| Nov 20, 2025 | Nov 20 10:19 PM | Catalys Pacific Fund, LP | Proposed Sale | 1,000,000 | $42.12 | $42.1M | — | View → |
| Nov 13, 2025 | Nov 13 9:04 PM | Karydas Daphne | Proposed Sale | 15,000 | $45.99 | $689.8K | — | View → |
| Nov 12, 2025 | Nov 13 9:03 PM | Gold Alexander M | Proposed Sale | 34,675 | $45.45 | $1.6M | — | View → |
| Nov 11, 2025 | Nov 12 9:32 PM | Levy Adam Scott | Proposed Sale | 119,524 | $44.88 | $5.4M | — | View → |
| Nov 11, 2025 | Nov 12 9:28 PM | Congleton Jon | Proposed Sale | 200,000 | $45.44 | $9.1M | — | View → |
| Oct 15, 2025 | Oct 15 8:09 PM | Rodman David Malcom | Proposed Sale | 10,369 | $43.01 | $446.0K | — | View → |
| Oct 13, 2025 | Oct 14 2:13 PM | Levy Adam Scott | Proposed Sale | 10,758 | $42.01 | $452.0K | — | View → |
| Oct 13, 2025 | Oct 14 2:09 PM | Congleton Jon | Proposed Sale | 15,100 | $42.67 | $644.3K | — | View → |
| Sep 15, 2025 | Sep 15 8:12 PM | Rodman David Malcom | Proposed Sale | 11,367 | $36.00 | $409.3K | — | View → |
| Aug 13, 2025 | Aug 13 9:21 PM | Rodman David Malcom | Proposed Sale | 11,365 | $12.93 | $147.0K | — | View → |
| Jul 30, 2025 | Jul 30 9:30 PM | Levy Adam Scott | Proposed Sale | 59,925 | $14.76 | $884.4K | — | View → |
| Jul 29, 2025 | Jul 30 1:29 PM | Levy Adam Scott | Proposed Sale | 807 | $14.00 | $11.3K | — | View → |
| Jul 28, 2025 | Jul 28 9:38 PM | Levy Adam Scott | Proposed Sale | 12,946 | $14.04 | $181.8K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,707 | $14.25 | 87,501(D) | View → |
| May 12, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 12,698(D) | View → |
| May 11, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 19,535(D) | View → |
| Apr 17, 2026 | Apr 21 10:59 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 416 | $15.44 | 4,584(D) | View → |
| Apr 13, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 14,058 | $14.25 | 91,667(D) | View → |
| Apr 9, 2026 | Apr 14 1:13 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,170 | $16.00 | 21,706(D) | View → |
| Mar 31, 2026 | Apr 2 10:53 PM | Daphne KarydasDirector | Option Exercise | 3,000 | $12.02 | 41,000(D) | View → |
| Mar 17, 2026 | Mar 17 8:51 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,000(D) | View → |
| Mar 13, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,709 | $14.25 | 95,834(D) | View → |
| Mar 12, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 25,395(D) | View → |
| Mar 9, 2026 | Mar 10 9:48 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 23,876(D) | View → |
| Feb 19, 2026 | Feb 21 12:49 AM | RA CAPITAL MANAGEMENT, L.P.Director | Grant/Award | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Jon CongletonDirector, Chief Executive Officer | Grant/Award | 187,900 | $28.06 | 187,900(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Glenn SblendorioDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Alexander M GoldDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Daphne KarydasDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 0(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Srinivas AkkarajuDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
Page 1 of 2
Next →